Welcome to the international HTA database

Showing [22042 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2002	Andalusian Health Technology Assessment Area (AETSA)	Report on the hearing-aid device AUDIGITAL ALFA 128
2002	National Institute for Clinical Excellence (NICE)	Guidance on the use of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer
2002	Medical Services Advisory Committee (MSAC)	Liquid based cytology for cervical screening
2002	National Institute for Clinical Excellence (NICE)	Guidance on the use of trastuzumab for the treatment of advanced breast cancer
2002	Medical Services Advisory Committee (MSAC)	Human papillomavirus testing in women with cytological prediction of low-grade abnormality
2002	National Institute for Clinical Excellence (NICE)	Guidance on the use of etanercept for the treatment of juvenile idiopathic arthritis
2002	Medical Services Advisory Committee (MSAC)	Intravascular brachytherapy
2002	National Institute for Clinical Excellence (NICE)	Guidance on the use of etanercept and infliximab for the treatment of rheumatoid arthritis
2002	Medical Services Advisory Committee (MSAC)	Magnetic resonance imaging for cholangeopancreatography
2002	West Midlands Health Technology Assessment Collaboration (WMHTAC)	Air travel as a risk factor for venous thromboembolism (VTE) and the effectiveness of preventive measures
2002	National Institute for Clinical Excellence (NICE)	Guidance on the use of rituximab for recurrent or refractory stage III or IV follicular non-Hodgkin's lymphoma (replaced by TA137)
2002	Medical Services Advisory Committee (MSAC)	Percutaneous transluminal coronary rotational atherectomy for lesions of the coronary arteries
2002	Canadian Coordinating Office for Health Technology Assessment (CCOHTA)	Carotid stenting for the treatment of carotid artery stenosis
2002	West Midlands Health Technology Assessment Collaboration (WMHTAC)	Expandable metal stents for inoperable oesophageal cancer
2002	National Institute for Clinical Excellence (NICE)	Inhaler devices for routine treatment of chronic asthma in older children (aged 5-15 years)
2002	Medical Services Advisory Committee (MSAC)	Recombinant human thyroid-stimulating hormone (rhTSH). Diagnostic agent for use in well-differentiated thyroid cancer
2002	Canadian Coordinating Office for Health Technology Assessment (CCOHTA)	Deep brain stimulation for patients with Parkinson's disease
2002	West Midlands Health Technology Assessment Collaboration (WMHTAC)	Fludarabine as first line therapy for chronic lymphocytic leukaemia
2002	National Institute for Clinical Excellence (NICE)	Guidance on the use of nicotine replacement therapy (NRT) and bupropion for smoking cessation
2002	Canadian Coordinating Office for Health Technology Assessment (CCOHTA)	Photonic stimulation for the treatment of chronic pain
2002	National Institute for Clinical Excellence (NICE)	Guidance on the use of infliximab for Crohn's disease
2002	Medical Services Advisory Committee (MSAC)	Transoesophageal echocardiography
2002	Canadian Coordinating Office for Health Technology Assessment (CCOHTA)	Spinal manipulation for lower back pain
2002	National Institute for Clinical Excellence (NICE)	Guidance on the use of routine antenatal anti-D prophylaxis for RhD-negative women
2002	Medical Services Advisory Committee (MSAC)	Selective internal radiation therapy for hepatic metastases using SIR-Spheres(R)
2002	Canadian Coordinating Office for Health Technology Assessment (CCOHTA)	Ultrasonic cutting and coagulating devices
2002	Medical Services Advisory Committee (MSAC)	M-VAX(TM) - a treatment for patients with advanced stage III melanoma
2002	NIHR Health Technology Assessment programme	Fludarabine as second-line therapy for B cell chronic lymphocytic leukaemia: a technology assessment
2002	Agencia de Evaluacion de Tecnologias Sanitarias (AETS)	Assessment of the effectiveness of health promotion and disease prevention technologies. IPE-02/36 (Public report)
2002	NIHR Health Technology Assessment programme	Rituximab as third-line treatment for refractory or recurrent Stage III or IV follicular non-Hodgkin's lymphoma: a systematic review and economic evaluation
2002	Health Technology Board for Scotland (HTBS) (merged into NHS Quality Improvement Scotland (NHS QIS)	Beta-interferon and glatiramer acetate for the treatment of multiple sclerosis
2002	NIHR Health Technology Assessment programme	The clinical effectiveness and cost-effectiveness of sibutramine in the management of obesity: a technology assessment
2002	NIHR Health Technology Assessment programme	The cost-effectiveness of magnetic resonance angiography for carotid artery stenosis and peripheral vascular disease: a systematic review
2002	ECRI	Helical CT for detection of lung cancer
2002	Agency for Healthcare Research and Quality (AHRQ)	Current validity of AHRQ clinical practice guidelines
2002	NIHR Health Technology Assessment programme	Promoting physical activity in South Asian Muslim women through 'exercise on prescription'
2002	NIHR Health Technology Assessment programme	A review of the natural history and epidemiology of multiple sclerosis: implications for resource allocation and health economic models
2002	ECRI	High-dose chemotherapy and stem cell transplantation for the treatment of systemic lupus erythematosus
2002	Canadian Coordinating Office for Health Technology Assessment (CCOHTA)	Extracorporeal immunoadsorption treatment for rheumatoid arthritis
2002	ECRI	High dose chemotherapy with allogeneic stem cell transplantation for Hodgkin's disease
2002	The Netherlands Organisation for Health Research and Development (ZonMw)	[Gynecological cancer: diagnostic value of radiological tests]
2002	Canadian Coordinating Office for Health Technology Assessment (CCOHTA)	Computer-enhanced surgical systems ('robotic surgery')
2002	Canadian Coordinating Office for Health Technology Assessment (CCOHTA)	Activated protein C for severe sepsis
2002	The Swedish Council on Health Technology Assessment (SBU)	Tobacco smoking and oral health
2002	ECRI	High-dose chemotherapy with autologous or allogeneic bone marrow or peripheral stem cell transplantation of neuroblastoma
2002	Canadian Coordinating Office for Health Technology Assessment (CCOHTA)	An assessment of oseltamivir for the treatment of suspected influenza
2002	HAYES, Inc.	Home uterine activity monitoring
2002	Canadian Coordinating Office for Health Technology Assessment (CCOHTA)	Clinical and economic assessment: infliximab for the treatment of Crohn's disease
2002	Canadian Coordinating Office for Health Technology Assessment (CCOHTA)	Infliximab for the treatment of Crohn's disease: a systematic review and cost-utility analysis
2002	The Swedish Council on Health Technology Assessment (SBU)	Prevention, diagnosis, and treatment of venous thromboembolism
2002	Canadian Coordinating Office for Health Technology Assessment (CCOHTA)	Radiofrequency catheter ablation for cardiac arrhythmias: a clinical and economic review
2002	Alberta Heritage Foundation for Medical Research (AHFMR)	Application of an assessment framework to an evolving telemental health program
2002	Alberta Heritage Foundation for Medical Research (AHFMR)	A study of the impact of 2000-2001 HTA products
2002	Basque Office for Health Technology Assessment (OSTEBA)	[Endoscopic and radiological techniques in the diagnosis and screening of colon cancer. Evaluation of the variability of use and acceptabilityy]
2002	HAYES, Inc.	Hyperthermia treatment for cancer, whole body
2002	Alberta Heritage Foundation for Medical Research (AHFMR)	Surgical treatment for chronic venous insufficiency
2002	Basque Office for Health Technology Assessment (OSTEBA)	[Low molecular weight heparins versus traditional heparins in thromboembolic diseases]
2002	New Zealand Health Technology Assessment (NZHTA)	Are different triage models associated with different outcomes in people presenting following suicidal ideation/threat/attempt? Evidence Tables
2002	Basque Office for Health Technology Assessment (OSTEBA)	[The effectiveness and safety of different forms of treating prostate cancer]
2002	New Zealand Health Technology Assessment (NZHTA)	Are there any crisis containment drug treatments that have been shown to be useful for reducing suicidality in short-term crises? Evidence Tables
2002	New Zealand Health Technology Assessment (NZHTA)	Are there any drug treatments that have been shown to increase the risk of suicide? Evidence Tables
2002	New Zealand Health Technology Assessment (NZHTA)	Does asking about suicidal ideation increase the likelihood of suicide attempts? Evidence Tables
2002	The Swedish Council on Health Technology Assessment (SBU)	Hormone replacement therapy
2002	New Zealand Health Technology Assessment (NZHTA)	Is there any evidence regarding the competency of different clinicians to do adequate suicide risk assessments? Evidence Tables
2002	The Swedish Council on Health Technology Assessment (SBU)	Obesity - problems and interventions
2002	New Zealand Health Technology Assessment (NZHTA)	What are the characteristics of repeating vs. non-repeating suicidal presenters to Emergency services? Evidence Tables
2002	New Zealand Health Technology Assessment (NZHTA)	What are the presenting complaints that should alert clinicians in emergency departments and tertiary mental health settings to the possibility of suicidal ideation/threat/attempts? Evidence Tables
2002	University of York	Homeopathy
2002	New Zealand Health Technology Assessment (NZHTA)	What evidence is there about the use of seclusion or containment for patients presenting with suicidal behaviours at emergency departments, tertiary mental health services or inpatient units? Evidence Tables
2002	University of York	Interventions for the management of CFS/ME
2002	New Zealand Health Technology Assessment (NZHTA)	What factors determine an inpatient admission as opposed to outpatient referral from emergency services? Evidence Tables
2002	Alberta Heritage Foundation for Medical Research (AHFMR)	Acupuncture: evidence from systematic reviews and meta-analyses
2002	New Zealand Health Technology Assessment (NZHTA)	What is the effectiveness of day care versus outpatient care versus community care for suicidal patients? Evidence Tables
2002	New Zealand Health Technology Assessment (NZHTA)	What is the efficacy of crisis interventions? Evidence Tables
2002	New Zealand Health Technology Assessment (NZHTA)	What is the efficacy of discharge planning protocols, i.e., managing the transition from hospital to community? What should be included in the plan? Evidence Tables
2002	Medical Advisory Secretariat (MAS)	Endovascular repair of abdominal aortic aneurysm: an evidence-based analysis
2002	Agency for Healthcare Research and Quality (AHRQ)	Systems to rate the strength of scientific evidence
2002	New Zealand Health Technology Assessment (NZHTA)	What is the relative efficacy of different suicide assessment tools regardless of the restrictions on who can administer these? Evidence Tables
2002	Medical Advisory Secretariat (MAS)	Gamma knife: an evidence-based analysis
2002	Alberta Heritage Foundation for Medical Research (AHFMR)	Efficacy and/or effectiveness of spirometry and force oscillation technique in the diagnosis of childhood asthma
2002	New Zealand Health Technology Assessment (NZHTA)	What kind of follow-up is needed to reduce the risk of repeated suicide attempts/suicide? Evidence Tables
2002	HAYES, Inc.	Intrathecal baclofen for cerebral palsy
2002	Medical Advisory Secretariat (MAS)	Bone anchored hearing aid (BAHA): an evidence-based analysis
2002	Alberta Heritage Foundation for Medical Research (AHFMR)	Metal-on-metal hip resurfacing for young, active adults with degenerative hip disease
2002	New Zealand Health Technology Assessment (NZHTA)	What clinical features best determine insulin resistance? Evidence Tables
2002	Alberta Heritage Foundation for Medical Research (AHFMR)	Priority setting in health care: from research to practice
2002	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	A systematic review of stapled haemorrhoidectomy
2002	Alberta Heritage Foundation for Medical Research (AHFMR)	Cryosurgery for prostate cancer
2002	Basque Office for Health Technology Assessment (OSTEBA)	[Tumour markers in certain cancer locations]
2002	Alberta Heritage Foundation for Medical Research (AHFMR)	Intracoronary brachytherapy for the treatment of in-stent restenosis
2002	The Swedish Council on Health Technology Assessment (SBU)	Preventing dental caries
2002	Alberta Heritage Foundation for Medical Research (AHFMR)	Stereotactic radiosurgery: an update
2002	The Swedish Council on Health Technology Assessment (SBU)	Testosterone replacement in men with age-related hormone deficiency - early assessment briefs (ALERT)
2002	Institute for Clinical Evaluative Sciences (ICES)	Health technology assessment of positron emission tomography in oncology - a systematic review
2002	The Swedish Council on Health Technology Assessment (SBU)	The maze procedure in treating atrial fibrillation - early assessment briefs (ALERT)
2002	Centre for Clinical Effectiveness (CCE)	Proton pump inhibitors versus H2 antagonists or placebo in treating bleeding peptic ulcer
2002	HAYES, Inc.	Ketogenic diet for refractory seizure control
2002	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	A systematic review of autologous fat transfer for breast augmentation
2002	Institute for Clinical Evaluative Sciences (ICES)	Prostate-specific antigen (PSA) screening in asymptomatic men
2002	The Swedish Council on Health Technology Assessment (SBU)	Microwave thermotherapy for benign prostatic hyperplasia - early assessment briefs (ALERT)